APA (7th ed.) Citation

D, G., A, K., HKK, V., V, V., N, L., C, I., . . . SM, S. (2026). FGTI-2734 prevents ERK-mediated resistance and enhances MRTX1133 efficacy in KRAS G12D pancreatic cancer. European journal of cancer (Oxford, England : 1990), 236, 116255. https://doi.org/10.1016/j.ejca.2026.116255

Chicago Style (17th ed.) Citation

D, Ghosh, Kazi A, Vasiyani HKK, Vudatha V, Lecomte N, Iacobuzio-Donahue C, Trevino J, and Sebti SM. "FGTI-2734 Prevents ERK-mediated Resistance and Enhances MRTX1133 Efficacy in KRAS G12D Pancreatic Cancer." European Journal of Cancer (Oxford, England : 1990) 236 (2026): 116255. https://doi.org/10.1016/j.ejca.2026.116255.

MLA (9th ed.) Citation

D, Ghosh, et al. "FGTI-2734 Prevents ERK-mediated Resistance and Enhances MRTX1133 Efficacy in KRAS G12D Pancreatic Cancer." European Journal of Cancer (Oxford, England : 1990), vol. 236, 2026, p. 116255, https://doi.org/10.1016/j.ejca.2026.116255.